RxDoctor Payments Data

Kelsey McCoy

Medical · Lebanon, VANPI 1689043952

Payments from drug & device makers

$3,375in general payments, 2019–2025

Across 205 payments — averaging $16.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$638
  • AbbVie$599
  • Neurocrine Biosciences, Inc.$466
  • Takeda Pharmaceuticals U.S.A., Inc.$237
  • Abbott$236
  • Otsuka America Pharmaceutical, Inc.$193
  • plus $1K from 13 others

What the payments were for

  • Food & beverage$3,375100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,375 in reported general payments places this provider in the 80th percentile of 632 medical providers in Virginia.

See all medical providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide96$108,654
EliquisApixaban91$78,222
MounjaroTirzepatide59$62,754
TrulicityDulaglutide61$58,154
JardianceEmpagliflozin50$38,097
JanuviaSitagliptin Phosphate33$33,068
TrintellixVortioxetine Hydrobromide51$30,034
LinzessLinaclotide49$29,824
FarxigaDapagliflozin Propanediol33$27,183
Nurtec OdtRimegepant Sulfate11$20,350
XareltoRivaroxaban28$18,558
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$14,433
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$14,014
SymbicortBudesonide/Formoterol Fumarate28$8,573
Breo ElliptaFluticasone/Vilanterol19$8,405

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$187$120,908120 claims
Novo NordiskOzempic$638$108,65496 claims
PfizerEliquis, Nurtec Odt$90$98,572102 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$148$49,77083 claims
AbbVieLinzess, Synthroid$599$31,42769 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$237$30,03451 claims
GSKTrelegy Ellipta, Breo Ellipta$71$22,83840 claims
Johnson & JohnsonXarelto$163$18,55828 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 632 medical providers in Virginia.

Other medical in Lebanon

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →